|
AMLX
|
Amylyx Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
ANVS
|
Annovis Bio, Inc.
|
US
|
NYSE
|
|
AXGN
|
AxoGen, Inc.
|
US
|
NASDAQ
|
|
CYTK
|
Cytokinetics, Incorporated
|
US
|
NASDAQ
|
|
CYTO
|
Altamira Therapeutics Ltd.
|
US
|
NASDAQ
|
|
ECOR
|
electroCore, Inc.
|
US
|
NASDAQ
|
|
LBPH
|
Longboard Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
NURO
|
NeuroMetrix, Inc.
|
US
|
NASDAQ
|
|
NVIV
|
InVivo Therapeutics Holdings Corp.
|
US
|
NASDAQ
|
|
TRVI
|
Trevi Therapeutics, Inc.
|
US
|
NASDAQ
|
|
BRRZD
|
Total Brain Ltd ADR
|
US
|
OTC
|
|
GBLX
|
GB Sciences, Inc
|
US
|
OTC
|
|
HRAL
|
HearAtLast Holdings Inc
|
US
|
OTC
|
|
TTBLF
|
Total Brain Ltd
|
US
|
OTC
|
|
AQS
|
Aequus Pharmaceuticals Inc.
|
CA
|
TSXV
|
|
BTI
|
biOasis Technologies Inc.
|
CA
|
TSXV
|
|
HRTIS
|
Herantis Pharma Oyj
|
FI
|
HE
|
|
EEP
|
Euroespes S.A
|
ES
|
MC
|
|
204840
|
IBKS No2 SPAC
|
KR
|
KQ
|
|
ALPHA
|
Pharnext SA
|
FR
|
PA
|